Section 4: Payment to pharmacy benefit consultants or brokers prohibited; conflicts of interest
[ Text of section added by 2024, 342, Sec. 37 effective April 8, 2025.]
Section 4. (a) A pharmacy benefit manager shall not make payments to a pharmacy benefit consultant or broker whose services were obtained by a health benefit plan sponsor to work on the pharmacy benefit bidding or contracting process if the payment constitutes a conflict of interest, as determined by the commissioner. For purposes of this section, payments from a pharmacy benefit manager to a pharmacy benefit consultant or broker shall include, but not be limited to: (i) shared rebates from pharmaceutical manufacturers; (ii) per prescription fees; (iii) per member fees; (iv) referral fees; (v) bonuses; or (vi) any other financial arrangement the commissioner considers to be a conflict of interest.
(b) The division shall adopt any written policies or procedures or promulgate regulations that the division determines are necessary to implement this section.